Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies. - Test2 - elhamkhani - TriplyDB

Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies.

Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies.

http://www.wikidata.org/entity/Q33847602

about

G Protein-Coupled Receptors (GPCRs) in Alzheimer's Disease: A Focus on BACE1 Related GPCRs Administration of a selective β2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease Amyloid β production is regulated by β2-adrenergic signaling-mediated post-translational modifications of the ryanodine receptor.One is the deadliest number: the detrimental effects of social isolation on cerebrovascular diseases and cognition.Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficits.Genetics of Frontotemporal Lobar Degeneration: From the Bench to the Clinic.Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening.Kinetics of Human Mutant Tau Prion Formation in the Brains of 2 Transgenic Mouse Lines.

P2860

Q26752403-E5B03114-A645-4F1E-8B17-DFE7FAA9A2C7 Q27307852-16B1E25C-BE79-4CDD-896B-EFBE2FFF2713 Q33806103-023EAEAF-1580-4C96-8580-C7424FDBD61A Q35204568-E67BB845-21CF-4456-9CC9-37ABE142EBAF Q38718079-CFAD5E3E-AA63-4E05-83A3-468A76BE73F1 Q38814847-E3603A15-FAE3-4023-ABAA-CAC9D0B83FCD Q42376445-9D304D76-9F85-4C1A-BD76-E68C693736DE Q46689694-FC5CACFA-A7BB-44F5-A0AB-7DEF450CE44F

P2860

Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies.

http://www.wikidata.org/entity/Q33847602

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Genetic suppression of β2-adre ...... a mouse model of tauopathies.

@ast

Genetic suppression of β2-adre ...... a mouse model of tauopathies.

@en

type

label

Genetic suppression of β2-adre ...... a mouse model of tauopathies.

@ast

Genetic suppression of β2-adre ...... a mouse model of tauopathies.

@en

prefLabel

Genetic suppression of β2-adre ...... a mouse model of tauopathies.

@ast

Genetic suppression of β2-adre ...... a mouse model of tauopathies.

@en

P1433

Q33847602-9033DB89-E4E9-4833-B3B9-40BD84A5B61F

P1476

Q33847602-51E991E9-FB36-4447-8ED3-4770E721C388

P2093

Q33847602-71982B09-D279-4245-8AB7-B4F485E77D85

Q33847602-8A79CEB7-5EBC-431A-9D7B-82783845AD8F

Q33847602-9B822666-33AE-4D84-BFEF-6CB51A5137EF

P2860

Q33847602-00550784-9725-4BAD-9147-ED4BC86E0F1C

Q33847602-08B0C299-3EF1-45C2-81C8-13A1147F1A9A

Q33847602-0A4B4CE5-50FD-49C6-B4ED-228A1E134FB3

Q33847602-0BF5730A-4C63-495A-AD0E-593A0AA0BC05

Q33847602-0DAFD7A1-3FCE-4737-9CA8-E1EB56390BEC

Q33847602-1362F4CB-2C01-48A7-9B87-DD52020AFE7D

Q33847602-161D6D3E-70E4-4AD5-9B6D-0273F2F6075C

Q33847602-1BED3AA4-D0C4-41D1-8D4E-66B4CBBA59EC

Q33847602-1D2173B1-1518-4667-BB2C-876EA85E739E

Q33847602-25FD71FB-F955-4E95-A838-B148D9592341

P304

Q33847602-EC49D25C-32CE-4B7A-A2E9-691E3D08AF74

P31

Q33847602-660AB9F0-B2B8-4814-927C-6AC4AAB479C0

P356

Q33847602-1B495FFC-3999-4B1F-8264-D332C64BBC19

P433

Q33847602-C9532752-9808-4631-8187-6DC7310CF298

P478

Q33847602-FF6AB095-D1AD-4BF9-AD1A-E88194F5DCCB

P577

Q33847602-85DB9205-6E9A-4008-8551-488F4FE47A9E

P5875

Q33847602-1F8CBD90-8705-417B-B54E-365BBD267484

P698

Q33847602-955D6776-E3D2-40E4-B132-973B591CB1B9

P932

Q33847602-DA33E1F3-F28D-48FD-AC4E-695C7BF5334B

P356

P1433

Human Molecular Genetics

P1476

Genetic suppression of β2-adre ...... a mouse model of tauopathies.

@en

P2093

Elena V Wisely

http://www.w3.org/2001/XMLSchema#string

Salvatore Oddo

http://www.w3.org/2001/XMLSchema#string

Yang K Xiang

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of activation of protein kinase B by insulin and IGF-1

Adrenergic pharmacology and cognition: focus on the prefrontal cortex

PKA: lessons learned after twenty years

Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model

Targeted disruption of the beta2 adrenergic receptor gene

Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth

Involvement of the amygdala in memory storage: Interaction with other brain systems

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

Binding of amyloid beta peptide to beta2 adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity

P304

4024-4034

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDU116

http://www.w3.org/2001/XMLSchema#string

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260809696

http://www.w3.org/2001/XMLSchema#string

P698

24626633

http://www.w3.org/2001/XMLSchema#string

P932

4082366

http://www.w3.org/2001/XMLSchema#string